Francesco Favero

9PUBLICATIONS
70CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer geneticsHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 16, 2026
The molecular heterogeneity and clinical impact of genomic driver alterations in prostate cancer.

|Sep 10, 2026
Integrated signatures define mutational processes in prostate cancer.

|Sep 09, 2026
Recurrent mechanisms of biallelic epigenetic inactivation reveal new putative tumour suppressor genes in prostate cancer.

|Feb 20, 2026
Hemizygous loss of helicases promotes genomic instability and cancer development.

Karolin Voßgröne, Francesco Favero, Krushanka Kashyap

|Dec 23, 2025
Clonal evolution and transcriptional plasticity shape metastatic dissemination routes in prostate cancer.

Migle Mikutenaite, Evdoxia Karadoulama, Francesco Favero

|Mar 24, 2020
Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study.

Simon Husby, Francesco Favero, Christian Nielsen

Pageof 2

Frequent Collaborators

7 joint publications

Joachim Weischenfeldt

4 joint publications

Thorsten Schlomm

4 joint publications

Clarissa Gerhäuser

4 joint publications

Robert G Bristow